KYTX · Insider trading · 13F holders · Congress trades
Kyverna Therapeutics Inc. (KYTX)
Who is buying and selling KYTX: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 10
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
KYTX at a glance
- No open-market insider purchases or sales of KYTX were filed in the last 90 days.
- 10 13F filers hold KYTX among their 50 largest positions, worth $148.0M combined. The biggest bets by portfolio weight are GordonMD Global Investments LP (18.3%), Caxton Corp (5.9%) and Propel Bio Management, LLC (4.1%). In their latest 13Fs, 1 manager opened a new position and 3 added to one.
- No member of Congress has disclosed a trade in KYTX.
KYTX insider trading
No open-market insider purchases or sales of KYTX were filed in the last 90 days.
Who owns KYTX? Hedge funds and superinvestors
10 13F filers hold KYTX among their 50 largest positions, worth $148.0M combined. The biggest bets by portfolio weight are GordonMD Global Investments LP (18.3%), Caxton Corp (5.9%) and Propel Bio Management, LLC (4.1%). In their latest 13Fs, 1 manager opened a new position and 3 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| GordonMD Global Investments LPHedge fund | 18.3% | $37.8M | 4,244,818 | +0.0% shares | Q2 2026 |
| Gilead Sciences, Inc.Corporation | 2.2% | $36.8M | 4,126,119 | +0.0% shares | Q2 2026 |
| Bain Capital Life Sciences Investors, LLCAsset manager | 1.5% | $25.7M | 2,885,000 | -7.2% shares | Q2 2026 |
| AIGH Capital Management LLCHedge fund | 2.3% | $24.9M | 2,795,797 | +39.8% shares | Q2 2026 |
| Insight Holdings Group, LLCInvestment manager | 0.7% | $8.8M | 989,054 | +0.0% shares | Q2 2026 |
| Propel Bio Management, LLCHedge fund | 4.1% | $7.9M | 883,198 | +37.1% shares | Q2 2026 |
| Mbb Public Markets I LLCInvestment manager | 0.6% | $5.5M | 614,477 | +0.0% shares | Q2 2026 |
| Act Capital Management, LLCHedge fund | 0.2% | $356K | 40,000 | +33.3% shares | Q2 2026 |
| Spark Investment Management LLCHedge fund | 0.4% | $224K | 25,100 | New | Q2 2026 |
| Caxton CorpInvestment manager | 5.9% | $110K | 12,347 | -34.2% shares | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 10). Screen KYTX in the grand portfolio →
KYTX stock trades by members of Congress
No member of Congress has disclosed a trade in KYTX.
KYTX questions and answers
Are insiders buying KYTX stock?
No open-market insider purchases or sales of KYTX were filed in the last 90 days.
Which hedge funds own KYTX?
10 13F filers hold KYTX among their 50 largest positions, worth $148.0M combined. The biggest bets by portfolio weight are GordonMD Global Investments LP (18.3%), Caxton Corp (5.9%) and Propel Bio Management, LLC (4.1%). In their latest 13Fs, 1 manager opened a new position and 3 added to one.
Has Congress traded KYTX?
No member of Congress has disclosed a trade in KYTX.
Who is the largest holder of KYTX?
Among 13F filers, GordonMD Global Investments LP reports the largest KYTX position, $37.8M (4,244,818 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is GordonMD Global Investments LP's: 18.3% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.